During the month of December, the number of shares and votes in SynAct Pharma AB (publ) have increased due to a directed issue of shares which was resolved upon by the board of directors on December 12, 2022, pursuant to the authorization granted by the annual general meeting on May 20, 2022.
Through the direct share issue, carried out in December 2022, the number of outstanding shares and votes has increased by 1,277,954, from 28,370,503 to 29,648,457. The share capital has increased by SEK 159,744.25, from SEK 3,546,312.875 to SEK 3,706,057.125.
As of December 30, 2022, the total number of shares and votes in SynAct Pharma AB amounts to 29,648,457 shares and votes.